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endemic and sporadic. The endemic form, also known as fogo selvagem, affects children and young
adults in rural Brazil while the sporadic form generally affects the middle-aged and the elderly. Here
we report a sporadic form of pemphigus foliaceus in a child in which the skin eruption responded to
ﬂucloxacillin. Upon discontinuation of ﬂucloxacillin, lesions reappeared and then cleared upon
resuming the antibiotic. Dapsone was thereafter administered with good control.
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Pemphigus foliaceus is a rare autoimmune blistering disease
mediated by IgG4, anti-desmoglein 1 autoantibodies (Qaqish
et al., 2009). Patients with PF will have direct immunoﬂuores-
cence deposits of IgG and C3 within the upper part of the epi-
dermis. There are two major subtypes of PF: endemic and
sporadic. The endemic form, mainly seen in rural areas of
Brazil, is known as fogo selvagem. Black ﬂy, Simulium.O. Box 7805, King Khalid
adh 11472, Saudi Arabia.
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transmission. The endemic type affects children and young
adults while the sporadic type affects the middle-aged individ-
uals and the elderly. The sporadic pemphigus foliaceus is rare
among children; thus clinical data and therapy to this group of
patients are lacking. We describe a 5-year-old girl with the dis-
ease who interestingly responded to ﬂucloxacillin, which has
not been described before.
2. Case report
A 5-year-old Saudi girl presented with 1 year history of a per-
sistent, mildly itchy, generalized skin eruption involving face,
neck and upper trunk. The skin eruption began at the perio-
ral skin spreading gradually over face and neck for which she
was given multiple topical remedies (unknown) by a pediatri-
cian without any improvement. She was then started on oral
prednisolone (dose was not speciﬁed) with good clearance of
the lesions but with recurrence upon tapering the dose. She
was kept on prednisolone for several months with signiﬁcant
increase in her weight; thus prednisolone was stopped and she
was referred to our dermatology clinic. She presented to us
Figure 1 (a) and (b) The classical presentation of pemphigus foliaceus in our patient in the form of polycyclic, serpiginous, crusted,
erythematous plaques over face.
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serpiginous, crusted, erythematous superﬁcial plaques over
her face, neck and upper trunk, Fig. 1. Mucous membranes
were not involved. The initial clinical impression was linear
IgA bullous dermatosis of childhood. Two skin biopsies were
taken for H&E and direct immunoﬂuorescence (DIF). Blood
tests were done including complete blood count, blood sugar
liver enzymes, urea, electrolytes and antinuclear antibodies.
All came within normal values. The child’s family lived far
away from the city and while waiting for the biopsy results,
the child was started on oral ﬂucloxacillin 250 mg three times
a day based on a previous experience with linear IgA bullous
dermatosis of childhood (Alajlan et al., 2006). Skin biopsy
showed upper epidermal acantholysis with neutrophilic inﬁl-
trates. DIF showed epidermal intercellular IgG and C3, con-
ﬁrming the diagnosis of pemphigus foliaceus (PF). Although
clinical, histopathological and DIF were consistent with
diagnosis of PF, the child showed good improvement of skin
lesions within the ﬁrst week of ﬂucloxacillin therapy. After
few weeks while on ﬂucloxacillin, the skin eruption mostly
cleared, Fig. 2. After 8 weeks, ﬂucloxacillin was tapered over
2 weeks. One month later the child started to develop similar
lesions over face and upper trunk that cleared again upon
resuming the antibiotic. The child was investigated for
glucose-6-phosphate dehydrogenase serum level (which came
to normal) prior to dapsone administration. Dapsone at a dose
of 25 mg was started and the lesions started to improve and
further cleared after 50 mg dose administration within 2 weeks.
Hemoglobin dropped 1.2 g (from 13.8 to 12.6 g/dl) in 1 week
but it stabilized thereafter.Figure 2 (a) and (b) Mostly clearance of3. Discussion
Childhood PF is commonly misdiagnosed as bacterial or fun-
gal infection, seborrheic dermatitis, atopic dermatitis or less
commonly psoriasis. Thus, it is not uncommon to have lag
time of several months before correct diagnosis can be made.
It seems that there is no relation between the prognosis and
such delay in the diagnosis. In histopathology, majority of pre-
vious cases in the literature were consistent with a diagnosis of
PF with the presence of upper epidermal acantholysis and neu-
trophilic and/or eosinophilic inﬁltrate. DIF usually conﬁrms
the diagnosis with IgG and C3 deposition at upper intracellu-
lar epidermis. Although rarely available, enzyme-linked immu-
nosorbent assay (ELISA) for the desmoglein 1 autoantibody
can successfully conﬁrm the diagnosis.
In this case, we have shown that ﬂucloxacillin was able to
completely control the skin eruption during its administration
which is similar to all the existing treatments for PF. Until
now, there is no curing therapy for PF till the spontaneous
remission occurs. To have a new effective medicine in the der-
matologists’ armamentarium, particularly for chronic illness, is
very helpful when other treatments cannot be used. The pro-
posed theory for ﬂucloxacillin effect on such immunobullous
disease is thought to be through its anti-inﬂammatory effects.
It has been shown that ﬂucloxacillin can control other immu-
nobullous disease; linear IgA bullous dermatosis of childhood
(Alajlan et al., 2006). There are not many examples in the lit-
erature of such anti-inﬂammatory effect of ﬂucloxacillin; how-
ever, other antibiotics such tetracycline group have been
shown to have an anti-inﬂammatory property both clinicallyskin lesions after ﬂucloxacillin therapy.
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and Menkes, 1987; Amato et al., 2002). Flucloxacillin is rela-
tively safe for short courses as it is evident by its wide use in
bacterial infections both in children and adults (Janknegt,
1997). However, a major adverse effect of ﬂucloxacillin is
cholestatic hepatitis that might rarely be fatal (Derby et al.,
1993; Devereaux et al., 1995; Koek et al., 1994). Other very
rare but signiﬁcant adverse effects of ﬂucloxacillin include
aplastic anemia, hemolytic anemia, agranulocytosis, acute
interstitial nephritis and acute renal failure (Xu and Murray,
2008; Tuffs and Manoharan, 1986; Burton et al., 1995; Bakker
et al., 1995; Dobson et al., 2005).
In PF, topical and systemic corticosteroids were used in
majority of the cases (Kahn and Lewis, 1971; Qureshi et al.,
1997). Dapsone, erythromycin (Perry, 1961), sulfapyridine
(Goodyear et al., 1991), chloroquine (Petratos and Andrade,
1967), corticotropin (ACTH) (Siregar et al., 1971) as well as
immunosuppressive therapy like azathioprine (Larregue
et al., 1980) and methotrexate (Wananukul and Pongprasit,
1999) were also used. Relative effectiveness among the various
agents used to treat PF was difﬁcult to assess because of multi-
ple factors: frequent use of overlapping agents, differences in
disease severity, and lack of clear or complete information
regarding time to disease resolution, total duration of therapy
and clinical outcome. The majority of those children reviewed
in the literatures were clear of disease, either off medication or
on low maintenance doses of medication, within 1 year,
regardless of the type of therapeutic intervention. However,
the longest follow up period available from the literature was
only 4 years (Ahmed and Salm, 1983). One death attributed
to the skin disease was reported (Perry, 1961).
In conclusion, the response of PF to ﬂucloxacillin was dra-
matic in 2 weeks and consistent over the 10 weeks period and
upon resuming the treatment in the second round. From our
experience, ﬂucloxacillin should be tried for further use in
immunobullous diseases.
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